Page last updated: 2024-08-25

sofosbuvir and Hepatic Insufficiency

sofosbuvir has been researched along with Hepatic Insufficiency in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brainard, DM; Curtis, C; Lasseter, K; Lawitz, E; Ling, KHJ; Marbury, T; Mathias, A; Mogalian, E; Moorehead, L; Murray, B; Osinusi, A; Perry, R1
Bichoupan, K; Branch, AD; Chang, C; Dieterich, DT; Grewal, P; Harty, A; Khaitova, V; Ku, L; Liu, L; Motamed, D; Patel, N; Perumalswami, PV; Schiano, TD; Woodward, M; Yalamanchili, R1
Beets, G; Beumont, M; Gutierrez, JA; Jacquemyn, B; Kakuda, TN; Lawitz, E; Luo, D; Ouwerkerk-Mahadevan, S; Picchio, G; Poordad, F; Van Eygen, V; Van Remoortere, P; Vandevoorde, A; Vijgen, L1

Trials

2 trial(s) available for sofosbuvir and Hepatic Insufficiency

ArticleYear
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
    Clinical pharmacokinetics, 2018, Volume: 57, Issue:11

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Carbamates; Drug Combinations; Drug Therapy, Combination; Female; Hepatic Insufficiency; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Sofosbuvir; Uridine; Young Adult

2018
Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease.
    Journal of viral hepatitis, 2017, Volume: 24, Issue:4

    Topics: Adult; Aged; Antiviral Agents; Carbamates; Drug-Related Side Effects and Adverse Reactions; Female; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Simeprevir; Sofosbuvir; Treatment Outcome; United States; Valine

2017

Other Studies

1 other study(ies) available for sofosbuvir and Hepatic Insufficiency

ArticleYear
High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens.
    Journal of viral hepatitis, 2016, Volume: 23, Issue:9

    Topics: Aged; Antiviral Agents; Bilirubin; Case-Control Studies; Decision Support Techniques; Female; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Incidence; Male; Middle Aged; Prognosis; Serum Albumin; Serum Albumin, Human; Simeprevir; Sofosbuvir; Survival Analysis

2016